{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:34:55Z","timestamp":1790969695284,"version":"4.1.0"},"reference-count":30,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"DOI":"10.1210\/jc.2008-2630","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T02:23:29Z","timestamp":1242181409000},"page":"2915-2921","source":"Crossref","is-referenced-by-count":124,"title":["Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis"],"prefix":"10.1210","volume":"94","author":[{"given":"Benjamin Z.","family":"Leder","sequence":"first","affiliation":[{"name":"Endocrine Unit, Department of Medicine (B.Z.L., R.M.N., J.J.W., S.M.B., J.S.F.), Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Neer","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Medicine (B.Z.L., R.M.N., J.J.W., S.M.B., J.S.F.), Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason J.","family":"Wyland","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Medicine (B.Z.L., R.M.N., J.J.W., S.M.B., J.S.F.), Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang W.","family":"Lee","sequence":"additional","affiliation":[{"name":"Biostatistics Center (H.W.L.), Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri-Ann M.","family":"Burnett-Bowie","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Medicine (B.Z.L., R.M.N., J.J.W., S.M.B., J.S.F.), Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Finkelstein","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Medicine (B.Z.L., R.M.N., J.J.W., S.M.B., J.S.F.), Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114001583500_R1","article-title":"Bone health and osteoporosis: a report of the Surgeon General","year":"2004","journal-title":"Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General"},{"key":"key\n\t\t\t\t2019041114001583500_R2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MED.0b013e32831a46d6","article-title":"Parathyroid hormone treatment for osteoporosis.","volume":"15","author":"Cosman","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"key\n\t\t\t\t2019041114001583500_R3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11914-008-0003-y","article-title":"Safety of parathyroid hormone for the treatment of osteoporosis.","volume":"6","author":"Miller","year":"2008","journal-title":"Curr Osteoporos Rep"},{"key":"key\n\t\t\t\t2019041114001583500_R4","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041114001583500_R5","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1359\/JBMR.040326","article-title":"Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.","volume":"19","author":"Ensrud","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114001583500_R6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","article-title":"One year of alendronate after one year of parathyroid hormone (1\u201384) for osteoporosis.","volume":"353","author":"Black","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114001583500_R7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00198-004-1713-3","article-title":"Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy.","volume":"16","author":"Kaufman","year":"2005","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114001583500_R8","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.","volume":"349","author":"Finkelstein","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114001583500_R9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00004424-198505000-00014","article-title":"Quantitative computed tomography for spinal density measurement. Factors affecting precision.","volume":"20","author":"Rosenthal","year":"1985","journal-title":"Invest Radiol"},{"key":"key\n\t\t\t\t2019041114001583500_R10","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis.","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114001583500_R11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1\u201334)] therapy on bone density in men with osteoporosis.","volume":"18","author":"Orwoll","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114001583500_R12","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1001\/archinte.164.18.2024","article-title":"Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis.","volume":"164","author":"Lindsay","year":"2004","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041114001583500_R13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00198-007-0485-y","article-title":"Effect of raloxifene after recombinant teriparatide [hPTH(1\u201334)] treatment in postmenopausal women with osteoporosis.","volume":"19","author":"Adami","year":"2008","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114001583500_R14","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1359\/JBMR.050501","article-title":"Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment.","volume":"20","author":"Prince","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114001583500_R15","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1210\/jcem.86.8.7736","article-title":"Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.","volume":"86","author":"Khosla","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114001583500_R16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/er.2008-0002","article-title":"Osteoporosis in men.","volume":"29","author":"Khosla","year":"2008","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114001583500_R17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-118-5-199303010-00003","article-title":"Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Assessment by use of biochemical markers.","volume":"118","author":"Cosman","year":"1993","journal-title":"Ann Intern Med [Erratum (1994) 120:698]"},{"key":"key\n\t\t\t\t2019041114001583500_R18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2265.1991.tb00302.x","article-title":"Skeletal responsiveness to parathyroid hormone in healthy females: relationship to menopause and oestrogen replacement.","volume":"34","author":"Joborn","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114001583500_R19","first-page":"511","article-title":"Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.","volume":"86","author":"Leder","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114001583500_R20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1210\/jc.2005-2495","article-title":"Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men.","volume":"91","author":"Lee","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114001583500_R21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/jcem-69-5-1024","article-title":"Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women.","volume":"69","author":"Tsai","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114001583500_R22","first-page":"2151","article-title":"Effects of gonadal suppression on the regulation of parathyroid hormone and 1,25-dihydroxyvitamin D secretion in women.","volume":"84","author":"Finkelstein","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114001583500_R23","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00198-008-0609-z","article-title":"Sex hormones, their receptors and bone health.","volume":"19","author":"Venken","year":"2008","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114001583500_R24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1196\/annals.1402.056","article-title":"Proresorptive actions of FSH and bone loss.","volume":"1116","author":"Zaidi","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"key\n\t\t\t\t2019041114001583500_R25","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1359\/jbmr.2002.17.9.1570","article-title":"Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.","volume":"17","author":"Bikle","year":"2002","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114001583500_R26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI113885","article-title":"Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures.","volume":"83","author":"Canalis","year":"1989","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114001583500_R27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11102-007-0035-9","article-title":"Normal levels of serum IGF-I: determinants and validity of current reference ranges.","volume":"10","author":"Brabant","year":"2007","journal-title":"Pituitary"},{"key":"key\n\t\t\t\t2019041114001583500_R28","doi-asserted-by":"crossref","first-page":"M176","DOI":"10.1093\/gerona\/53A.3.M176","article-title":"Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men","volume":"53","author":"O'Connor","year":"1998","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key\n\t\t\t\t2019041114001583500_R29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1359\/jbmr.071103","article-title":"Longitudinal changes in BMD and bone geometry in a population-based study.","volume":"23","author":"Lauretani","year":"2008","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114001583500_R30","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1359\/jbmr.040916","article-title":"Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites.","volume":"19","author":"Riggs","year":"2004","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/8\/2915\/9065975\/jcem2915.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T01:18:54Z","timestamp":1558315134000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/8\/2915\/2596980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,1]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-2630","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,1]]}}}